Efficacy News and Research

RSS

Researchers Discover Key Protein Mechanism Enabling Fungal Drug Resistance

The battle lines have finally shifted in the war against a deadly fungal disease.

5 Oct 2026

Dr. GPCR and Eurofins Discovery Join Forces to Advance GPCR Drug Discovery

Dr. GPCR, the global knowledge hub for G protein-coupled receptor (GPCR) research and education, today announced a strategic partnership with Eurofins Discovery, the drug discovery services side of the same group behind the Eurofins DiscoverX products many in the community already know.

From Dr. GPCR 5 Oct 2026

Novel Therapeutic Approaches for Malaria Using Anti-Cancer Compound Derivatives

Molecules known for their anti-cancer activity have proven effective in combating Plasmodium falciparum, the parasite that causes malaria.

30 Sep 2026

AI-Designed Synthetic Polymers Mimic Natural Peptides to Beat Superbug Resistance

Swimming through the blood, sweat, cells, and tears of all humans are tiny proteins referred to as peptides.

25 Sep 2026

Cancer-Associated Fibroblasts Construct Physical Barriers Limiting Antitumor T Cell Infiltration

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown pathway that prostate tumors leverage to suppress the immune system by reshaping the tumor microenvironment to resist treatment.

25 Sep 2026

Trans-spliceosome Architecture Maps Evolutionary Divergence in Eukaryotic RNA Processing

A study conducted between the University of Liège and Rockefeller University reveals, with near-atomic precision, the three-dimensional structure and function of a gigantic molecular machine essential to the survival of trypanosomatid parasites, which cause serious diseases in humans, animals and plants.

24 Sep 2026

Activating TRPC1 Protein Channels With Magnetic Fields Triggers Cancer Phagocytosis

Researchers from the National University of Singapore (NUS) have demonstrated an innovative approach for targeted breast cancer therapy using pulsed electromagnetic fields (PEMFs).

15 Sep 2026

Engineered Citrus Enzyme Transforms Upstream Precursors Into Bioactive Flavones

Polymethoxyflavones (PMFs) accumulate mainly in the colored outer peel, or flavedo, of citrus fruit and are associated with anticancer, anti-inflammatory, metabolic-protective, and neuroprotective activities reported in experimental studies.

12 Sep 2026

Engineering Stem-Cell-Derived Immune Cells to Teach T Cells to Fight Cancer

The human body contains vast numbers of T cells capable of seeking out and eliminating malignancies if they were properly activated. Currently, a group from UC San Francisco has developed a technique to achieve this by merging laboratory-cultivated immune cells with samples from a person's malignancy.

26 Aug 2026

New Lipid Vesicles Evade Immune Cells to Target Cancer Tumors

Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments.

18 Aug 2026

Batista Lab Identifies Crucial Protein Targets to Extend Malaria Vaccine Efficacy

A study reveals how targeting specific protein regions in malaria vaccines could enhance efficacy, potentially saving more lives in vulnerable populations.

11 Aug 2026

Stable RNA Structures Revolutionize Quality of Life in Oncology Care

A new review highlights the growing importance of circular RNAs (circRNAs) in addressing one of the most pressing challenges in modern oncology: treatment-related toxicity.

6 Aug 2026

T Cells Identify Dangerous Pathogenic Threats to Keep Bodies Healthy

Your body depends on T cells to stay healthy. These white blood cells act like a neighborhood watch in the body, helping the immune system spot threats such as viruses, bacteria, and cancer cells.

3 Aug 2026

New Molecule Restores Muscle Repair Signal Linked to Age-Related Muscle Loss

One of the first tissues to deteriorate with aging is skeletal muscle. Weakness, scarring, internal muscle fat accumulation, and the loss of fast-twitch muscle fibers—which are crucial for rapid and forceful movements—can result from this deterioration.

27 Jul 2026

A Bio-Based Janus Dressing That Targets Bacteria At Wound Sites

Bio-based furan polyamide dressings effectively direct antibiotic release, offering a sustainable solution for early bacterial control in wounds.

27 Jul 2026

Kobe University Unveils Mass-Producible Off-the-Shelf Cancer Fighters

Off-the-shelf and mass-producible immune cells fight solid human tumors engrafted into mice. The Kobe University development is a significant contribution towards faster and cheaper cancer immunotherapy.

24 Jul 2026

Artificially Recreating C3 Effects Overcomes Resistance in Hard-to-Treat Tumors

An ancient molecule that existed long before the blood circulation system evolved, has been found to support cancer immunotherapy. Researchers at Nagoya University in Japan found that complement C3 protein acts inside tumors to prevent the accumulation of immunosuppressive cells, but only when produced inside the tumor.

23 Jul 2026